𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor

✍ Scribed by Richon, V M

Book ID
109999001
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
149 KB
Volume
95
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Histone deacetylase inhibitor, suberoyla
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
✍ Takashi Kumagai; Naoki Wakimoto; Dong Yin; Sigal Gery; Norihiko Kawamata; Noriyu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 461 KB πŸ‘ 1 views

## Abstract Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated by histone deacetylase (HDAC). HDAC inhibitors can block cancer cell growth by restoring expression of tumor suppressor genes. In th

The histone deacetylase inhibitor, suber
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
✍ Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 958 KB

## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt